Get Started

RLAY

NASD Relay Therapeutics, Inc.
Nov 5, 2026 · 9:19 AM ET LAST TRADE Market Closed

$17.29 ↓ -0.74 (-4.10%) Trading Down from the previous close of $18.03

YTD change
+104.37%
vs 20-day SMA
-3.67%
vs 200-day SMA
+14.13%

Price ranges

Previous day
$17.08 $18.28
open $17.57 close $18.03
+$0.46 (+2.62%)
Today
$0.00 $0.00
$17.29
Past week
$17.08 $20.20
from $19.69 now $17.29
-$2.40 (-12.19%)
Past month
$16.13 $20.20
from $17.95 now $17.29
-$0.66 (-3.68%)
This year
$7.01 $21.27
from $8.46 now $17.29
+$8.83 (+104.37%)

Price & Performance

+5.03 (+38.69%) / 6M

$11.38$14.73$18.09$21.44May 5Aug 5Nov 4

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 73.1% away from all-time highs of $64.37
  • RLAY is up 104% since the beginning of the year
  • RLAY is up 164% over the past 12 months
  • RLAY is down 4% over the past 1 month
  • 26% of all RLAY investors are betting against RLAY

RLAY reads not so good: price sits above one of the two key moving averages, the 12-month move is +175.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.37
Earnings momentum -11.4% Quarterly EPS growth
Quarterly change -11.4%

Valuation

P/E ratio N/A
Enterprise value $2.8B
Beta 1.82

Balance sheet & scale

IncomeN/A
Revenue$10.3M
Cash$910.9M
Debt$30.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $3.8B

Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $478.48 +3.73%
MRNA Moderna, Inc. $258.38 +13.11%
RVMD Revolution Medicines, Inc. $199.70 +2.82%
ROIV Roivant Sciences Ltd. $38.23 +6.08%
BNTX BioNTech SE Sponsored ADR $90.70 +4.35%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.